Michael Reese Endowed Professorship in Hematology

Damiano Rondelli, MD

Message of Gratitude to Michael Reese Research and Education Foundation


The support of the MRREF has been and still is instrumental is working on translational research that I anticipate will allow us to design new clinical trials in stem cell transplantation. The work of the last few years is being published (one paper recently published and others under preparation) and presented nationally and internationally. It

is an honor for me to have the Michael Reese Foundation name always attached to mine all over the world, including on social media where hundreds of people follow me on LinedIn or Twitter where I discuss hematologic or global health topics.

Top 2017 accomplishments


- 2017 UIC Department of Medicine Faculty of the Year


Recent Article/Video Links: http://abc7.ws/2xK9wQj

https://news.uic.edu/first-patient-cured-of-rare-blood-disorder-2


http://abc7chicago.com/health/chicago-doctors-use-stem-cells-to-cure-sickle-cell- disease/1652719/


Conferences attended/spoken at:



Published papers:


Patel P, Rondelli D (April 2017). The Bottom Line: Total Marrow and Lymphoid Irradiation to Rescue Refractory Leukemia. Biology of Blood and Marrow Transplantation, 23(4):536-537.

Oh A, Patel P, Aardsma N, Mehendale SR, Chowdhery R, Sweiss K, Rondelli D (March 2017). Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia. Bone Marrow Transplantation, 52(6).

Oh A, Ghimire K, Kalakota N, Sweiss K, Patel P, Rondelli D (March 2017). Cytopenia of Unknown Cause as a Predictive Marker of Clinical Outcome Post Busulfan Based Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation, 23(3): S291.

Patel P, Oh A, Senyuk V, Mahmud D, Mahmud N, Rondelli D (March 2017). Inhibition of PARP and DNA-PK Lead to Synergistic Cytotoxicity with Melphalan in Multiple Myeloma. Biology of Blood and Marrow Transplantation, 23(3): S269.

Sweiss K, Oh A, Calip GS, Quigley J, Rondelli D, Patel P (March 2017). Acute Kidney Injury before Day 90 Predicts for Poor Overall Survival after FluBu4. Biology of Blood and Marrow Transplantation, 23(3): S303-S304.

Patel P, Oh A, Koshy M, Sweiss K, Saraf S, Quigley J, Khan I, Mahmud N, Hacker E, Ozer H, Peace D, Weichselbaum RR, Aydogan B, Rondelli D (March 2017). Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/Refractory Multiple Myeloma: A Phase 1 Study. Biology of Blood and Marrow Transplantation, 23(3): S85.

Sweiss K, Oh A, Calip GS, Rondelli D, Patel P (December 2016). Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era. Blood, 128(22):4631.

Patel P, Senyuk V, Bonetti E, Mahmud D, Kadkol S, Oh A, Mahmud N, Rondelli D (December 2016). The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms. Blood, 128(22):4276.


Cruz CH, Uria JC, Perurena JM, Yribar WT, de la Campa JD, Fraga YR, Silva JAL, Perez IM, Rodriguez CR, Llauger KC, Ramirez IKP, Sweiss K, Patel P, Rondelli D (December 2016). Blood and Marrow Transplantation (BMT) in Adult ACUTE Leukemia Patients in Cuba: Current Results and Future Opportunities through International Collaboration. Blood, 128(22):5959.

Sweiss K, Anderson J, Wirth S, Quigley J, Khan I, Oh A, Rondelli D, Patel P (December 2016). A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy. Blood, 128(22):2207.

Hacker E, Collins E, Park C, Peters T, Rondelli D (October 2016). Strength training to enhance early recovery after hematopoietic stem cell transplantation. Journal of Clinical Oncology, 34(26):190-190.

Bhave SR, Koshy M, Akthar AS, Sengul A, Weichselbaum RR, Patel P, Rondelli D, Aydogan B (October 2016). Prospective Assessment of Radiation Dose Toxicity Correlations in Patients Who Received Intensity Modulated Total Marrow Irradiation (IM-TMI) as Part of Conditioning Regimen Prior to Stem Cell Transplant.

International Journal of Radiation Oncology, Biology, Physics, 96(2S):E501.


Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK. Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase 2 Study and CIBMTR Outcomes. Biol Blood Marrow Transplant. 2016 Jul;22(7):1197-205. PMID: 27040394

Sweiss K, Culos K, Patel S, Oh AL, Rondelli D, Patel PR. Melphalan 200 Mg/m2 in Patients with Renal Impairment Is Associated with Increased Short Term Toxicity but Improved Response and Longer Treatment-Free Survival. Bone Marrow Transplant. 2016 Oct;51(10):1337-1341. PMID: 27183094

Hacker ED, Collins E, Park C, Peters T, Patel P, Rondelli D. Strength Training to Enhance Early Recovery (STEER) Following Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Dec 29. pii: S1083- 8791(16)31215-0. doi: 10.1016/j.bbmt.2016.12.637. [Epub ahead of print] PMID: 28042020